NF-kappaB decoy gene therapy (Dainippon)

N/A

Report date: 2026/01/27 10:13:58
NME

Base Information

Drug NameNF-kappaB decoy gene therapy (Dainippon)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionCell adhesion molecules modulatorsNuclear factor NF-kappa-B complex modulatorsCytokines modulators
TargetsNuclear factor NF-kappa-B complexCell adhesion moleculesCytokines
Therapy Area/IndicationsGlomerulonephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDainippon Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDainippon Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsGlomerulonephritis

Other Information

ATC CodeN/A
Related LinksN/A